Canada
· Delayed Price · Currency is CAD Voyageur Pharmaceuticals Statistics
Total Valuation
TSXV:VM has a market cap or net worth of CAD 26.49 million. The enterprise value is 25.89 million.
| Market Cap | 26.49M |
| Enterprise Value | 25.89M |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:VM has 160.55 million shares outstanding. The number of shares has increased by 7.97% in one year.
| Current Share Class | 160.55M |
| Shares Outstanding | 160.55M |
| Shares Change (YoY) | +7.97% |
| Shares Change (QoQ) | +11.57% |
| Owned by Insiders (%) | 8.58% |
| Owned by Institutions (%) | n/a |
| Float | 146.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 22.33 |
| P/TBV Ratio | 22.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.79 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.51 |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 0.03.
| Current Ratio | 0.46 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -158.96% and return on invested capital (ROIC) is -83.24%.
| Return on Equity (ROE) | -158.96% |
| Return on Assets (ROA) | -41.38% |
| Return on Invested Capital (ROIC) | -83.24% |
| Return on Capital Employed (ROCE) | -152.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +200.00% in the last 52 weeks. The beta is 0.79, so TSXV:VM's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +200.00% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 46.09 |
| Average Volume (20 Days) | 124,450 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.89M |
| Pretax Income | -2.20M |
| Net Income | -2.20M |
| EBITDA | -1.89M |
| EBIT | -1.89M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 642,485 in cash and 40,000 in debt, giving a net cash position of 602,485 or 0.00 per share.
| Cash & Cash Equivalents | 642,485 |
| Total Debt | 40,000 |
| Net Cash | 602,485 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.19M |
| Book Value Per Share | 0.01 |
| Working Capital | -1.04M |
Cash Flow
In the last 12 months, operating cash flow was -1.50 million and capital expenditures -170,839, giving a free cash flow of -1.67 million.
| Operating Cash Flow | -1.50M |
| Capital Expenditures | -170,839 |
| Free Cash Flow | -1.67M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:VM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.97% |
| Shareholder Yield | -7.97% |
| Earnings Yield | -8.29% |
| FCF Yield | -6.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |